As of 2026-06-15, the Fair Value of Novavax Inc (NVAX) is -13.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.88 USD, the upside of Novavax Inc is -250.38%.
With the market price of 8.88 USD and our fair value calculation, Novavax Inc (NVAX) is not a good investment. Investing in Novavax stocks now will result in a potential loss of 250.38%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -1,743.80 | -657.90 | -545.06 | -187.50 | 440.30 | -538.79 |
| YoY growth | -316.88% | 62.27% | 17.15% | 65.60% | 334.83% | 32.59% |
| Market Cap (mil) | 1,460.23 |
| P/E | |
| Forward P/E | 15.83x |
| EPS | -0.53 |
| Avg earnings growth rate | 32.59% |
| TTM earnings | -87.83 |